The pharmaceutical company that makes the generic version of the widely used abortion pill mifepristone filed a lawsuit against the Food and Drug Administration on Wednesday in an effort to keep the drug on the market.
Among the moves blocked by the U.S. Court of Appeals for the 5th Circuit was the FDA's 2019 approval of a GenBioPro's application to market a generic version of mifepristone. The Supreme Court issued a temporary order last week preserving access to the drug until 11:59 p.m. Wednesday, and the hold wasGenBioPro's lawsuit against the FDA is the latest in a legal barrage involving medication abortion that has thrown the availability of mifepristone into uncertainty.
GenBioPro, the country's only manufacturer of generic mifepristone, is asking the court to block the FDA from depriving it"of its constitutional and statutory rights to market mifepristone without affording GenBioPro due process of law." The agency said it does not comment on possible, pending or ongoing litigation.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Abortion pill manufacturer sues FDA to keep drug on the marketThe Supreme Court is expected to rule today on whether to impose restrictions to abortion pills.
Read more »
Abortion Pill Manufacturer Sues FDA to Protect Mifepristone AccessGenBioPro, the manufacturer of a generic version of the abortion pill mifepristone, sued the Food and Drug Administration on Wednesday to prevent the drug from being taken off the market.
Read more »
Abortion pill manufacturer sues to keep FDA approval amid court battleAbortion pill manufacturer GenBioPro filed suit against US_FDA to maintain its ability to market the drug. GenBioPro manufactures a generic version of mifepristone, the first drug in a two-step chemical abortion process.
Read more »
Abortion pill company GenBioPro asks U.S. court to keep generic mifepristone on marketThe Supreme Court is considering whether to maintain a court order that would severely restrict access to the abortion drug mifepristone.
Read more »
Abortion pill manufacturer fights to save generic mifepristoneGenBioPro, the only domestic manufacturer of mifepristone, filed a lawsuit Wednesday against the Food and Drug Administration in an attempt to block the agency from taking the drug off the market.
Read more »
As Supreme Court Weighs Next Steps on Abortion Pill, Protesters Rally and Pharma Company GenBioPro Sues FDA to Restore AccessAs the Supreme Court weighs its options on the abortion pill mifepristone, abortion and women’s rights supporters across the U.S. are protesting the latest efforts to restrict access to abortion.
Read more »